Sam Chun Dang Pharm said it secured an exclusive contract to supply its Eylea biosimilar to nine Western European countries, including the U.K., Belgium, the Netherlands, Norway, Portugal, Sweden, Greece, Ireland, and Finland.Under the accord, Sam Chung Dang will receive 55 percent of the total sale
Pharma
Lee Han-soo
2024.03.25 14:47